Design, synthesis and antiasthmatic activities of NO-donating seratrodast derivatives

Yaoxue Xuebao

Volumn 39, Issue 9, 2004, Pages 705-710

  Zhang, Zhi Guo ^a   Zhang, Yi Hua ^a   Ji, Hui ^a   Qiu, Su Gan ^a   Feng, Xiao Chun ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Antiasthmatic activities; NO; No donating seratrodast; Seratrodast

Indexed keywords

ACETYLCHOLINE; ANTIASTHMATIC AGENT; FURAZOLIDONE; GUANIDINE DERIVATIVE; HISTAMINE; NITRIC OXIDE; SERATRODAST; TRIAZOLE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTHMA; CONTROLLED STUDY; DRUG ACTIVITY; DRUG DESIGN; DRUG EFFECT; DRUG MECHANISM; DRUG STRUCTURE; DRUG SYNTHESIS; GUINEA PIG; INFRARED SPECTROSCOPY; MASS SPECTROMETRY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; STRUCTURE ANALYSIS;

ACETYLCHOLINE; ANIMALS; ANTI-ASTHMATIC AGENTS; ASTHMA; BENZOQUINONES; GUANIDINES; GUINEA PIGS; HEPTANOIC ACIDS; HISTAMINE; NITRIC OXIDE; NITRIC OXIDE DONORS; OXADIAZOLES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 11444261407     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Burgaud JL, Riffaud JP, Del Soldato P. Nitric-oxide releasing molecules: a new class of drugs with several major indications [J]. Curr Pharm Design, 2002,8(3): 201-213.
2. Zhang Y, Palette-Pays C, Naline E, et al. Effect of molsidomine and linsidomine on the human isolated bronchus and the guinea-pig isolated trachea [J]. J Pharm Pharmacol, 1993,45(4):280-285.
3. 2-adreno- receptor agonist and NO donors in the relaxation of guinea pig trachea in vitro [J]. Eur J Pharmacol, 1998,363(2):169-174.
4. Hernandez M, Elmedal B, Mulvany MJ, et al. Mechanisms of relaxations of brovine isolated bronchioles by the nitric oxide donor, GEA 3175 [J]. Br J Pharmacol, 1998,123(5):895-905.
5. Ward C, Wong TH, Murray J, et al. Induction of human neutrophil apoptosis by nitric-oxide donors: evidence for a caspase-dependent, cyclic GMP-independent, mechanism [J]. Biochem Pharmacol, 2000,59(3):305-314.
6. Valli K, Li L, Redemann B, et al. In vitro brochorelaxing effects of novel nitrix oxide donors GEA 3268 and GEA 5145 in guinea-pigs and rats [J]. J Pharm Pharmacol, 1996,18(12):895-905.
7. Katsutada M, Takaaki K, Kenichi K. Studies on mesoionic compounds. III. Synthesis of ψ-3-aryl-5-imimo-3, 5-dihydro-1-oxa-2, 3, 4-triazole hydrochlorides and their derivatives [J]. Chem Pharm Bull, 1971,19 (3):559-563.
8. Alhede BI, Petersen SB, Clausen FP, et al. 3-Substituted 1, 2, 3, 4-oxatriazole-5-imine compounds, a process for the preparation thereof and a pharmaceutical preparation containing said compounds [P]. WO Pat: 9213847, 1995-04-11.
9. Aoki M. Preparation of carbonic acid esters of 2-hydroxyguanidines as intermediates for dyes, photographic couplers, drugs, and pesticides [P]. JP: 2001316350 A2, 2001-11-13.
10. Wang WD, Zhang YH, Jin H, et al. Synthesis and antiinflammatory activities of NO releasing-Flobufen derivatives [J]. Chin J Med Chem, 2004,14(1):1-8.
11. Xu SY, Bian RL, Chen X. Methodology of Pharmacology Experiment [M]. 3rd Ed. Beijing: People's Medicinal Publishing House, 2002.911.
12. Gasco AM, Boschi D, Stilo AD, et al. Characterization of furoxan- carbonitiles as a new class of vasodilators [J]. Arzneim-Forsch / Drug Res, 1998,48(1):212-218.
13. Sorba G, Medana C, Fruttero R, et al. Water soluble furoxan derivatives as NO prodrugs [J]. J Med Chem, 1997,40(4):463-469.
14. Yu XL, Ji H, Zhang YH, et al. Pharmacological activity screening of furan-coupled diclofenac compounds [J]. J China Pharm Univ, 2001,32 (4):301-305.